School of Medicine
Showing 851-900 of 1,146 Results
-
Allyson Rosen, Ph.D., ABPP-CN
Clinical Professor (Affiliated), Psych/Public Mental Health & Population Sciences
Staff, Psychiatry and Behavioral SciencesBioRESEARCH FOCUS
Translational cognitive neuroscience of aging and dementia. Neuroethics.
TRAINING
Dr. Rosen is board certified in clinical neuropsychology with a geriatric focus. She completed college at Brown University, a clinical psychology Ph.D. from Case Western Reserve University, clinical neuropsychology internship at the Long Island Jewish Hospital in New York, and clinical neuropsychology postdoctoral fellowship at the Medical College of Wisconsin. Dr. Rosen completed specialty research fellowship training at the National Institute on Aging (Intramural Research Training Award) and Stanford (NRSA F32, K01) in functional imaging and noninvasive brain stimulation with support from NIA.
CLINICAL AND RESEARCH ACTIVITIES
Dr. Rosen is Director of Dementia Education at the Mental Illness Research Education and Clinical Center at the Palo Alto VAHCS. She is also a neuropsychologist and part of the consensus clinical group and education core at the Stanford’s Alzheimer’s Disease Research Center (NIA). Dr. Rosen’s funded research has focused on applying cognitive neuroscience of aging to improve clinical practice in older adults by using cognitive measures, brain imaging, and noninvasive brain stimulation such as TMS. Studies include using fMRI as an outcome measure for cognitive training, studying how to improve the accuracy of transcranial magnetic stimulation targeting with and without image guidance, and using structural MRI to avoid postoperative cognitive decline and improve outcome from carotid vascular procedures. She has a longstanding commitment to neuroethics and leads a feature in the Journal of Alzheimer Disease that focuses on ethical issues in new and emerging AD applications.
ETHICS EDITOR, JOURNAL OF ALZHEIMER'S DISEASE
Ethics Review
http://www.j-alz.com/blogs/discussion/protecting-progress
MIRECC DEMENTIA EDUCATION
http://www.mirecc.va.gov/visn21/education/dementia_education.asp -
Craig S. Rosen, Ph.D.
Professor of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
Current Research and Scholarly InterestsMy research aims at improving processes and outcomes of mental health care for veterans other people suffering from post-traumatic stress and other mental disorders.
My primary focus is improving access to evidence-based treatments PTSD and other psychiatric disorders. My second emphasis is using telemedicine technologies to expand access to effective care. My third interest is measurement-based care, using ongoing data on patient progress to inform patients' and clinicians' decisions. -
Eve Alexandra Rosenfeld
Postdoctoral Scholar, Psychiatry
BioEve Rosenfeld is a postdoctoral fellow in VA's Advanced Fellowship Program in Mental Illness Research and Treatment at the National Center for PTSD, Dissemination & Training Division (NCPTSD D&T), VA Palo Alto Health Care System and the Department of Psychiatry and Behavioral Sciences, Stanford University. She is also the Diversity, Equity, and Inclusion Coordinator at NCPTSD D&T. Her research focuses on harnessing digital interventions such as mobile apps to increase access to evidence-based care for PTSD, particularly for marginalized communities such as the LGBTQ+ and Latinx communities.
-
Jessica M. Ross, PhD
Postdoctoral Scholar, Psychiatry
BioDr. Ross uses transcranial magnetic brain stimulation (TMS) and electroencephalography (EEG) for her research on neuromodulation-based psychiatric treatments, and on aberrant brain plasticity, cortical reactivity, and connectivity in older adults with cognitive disorder and healthy adults.
-
Fernanda Rossi, Ph.D.
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Rossi’s research focuses on developing, evaluating, and implementing assessment tools and interventions to improve the safety and mental health of individuals at risk of intimate partner violence, suicide, and drug overdose. She is particularly interested in using technology and clinical decision support tools to enhance the quality and implementation of intimate partner violence-, suicide-, and substance use-related care.
-
Maryam Rostami
Professional-NX, Psychiatry and Behavioral Sciences
BioMaryam Rostami is a professional data analyst in the Department of Psychiatry and Behavioral Science at Stanford university, currently working in the area of neuroethics and public health. She got a PhD in cognitive neuroscience and neuroimaging from Tohoku university/Japan that folloed by two years of research in the same area at Stanford university.
-
Walton T. Roth
Professor of Psychiatry & Behavioral Sciences, Emeritus
Current Research and Scholarly InterestsLaboratory and ambulatory recording of physiological, responses to stressors in anxious and phobic patients.
-
Cristin Runfola
Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsDr. Runfola's research focuses on the epidemiology of dysregulated eating and weight concerns in undeserved populations and her primary interest is in developing and testing the efficacy of clinical interventions designed to improve outcome for eating disorders.
With support from GFED, Dr. Runfola adapted the Uniting Couples in the treatment of Anorexia Nervosa (UCAN) therapy manual for couples in which one or both members have binge-eating disorder (UNITE) and recently completed pilot testing on this treatment. She is in the process of expanding this treatment for all couples affected by binge eating, and is submitting a grant to fund future work testing efficacy. -
Samuel Ricardo Saenz
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Sam Saenz was born in the Bay Area and received his bachelor’s degree in psychology from Stanford University. He completed his medical degree at UC Irvine’s Program in Medical Education for the Latino Community, and he also obtained a Master’s in Public Health from UC Berkeley. After serving as chief psychiatry resident during his psychiatry residency at Stanford, he completed a fellowship in public psychiatry at UC San Francisco. His professional interests include fostering the next generation of diverse mental health providers as well as advancing justice, equity, and inclusion (JEDI) work in academic medicine.
-
Debra Safer
Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology-Adult)
Current Research and Scholarly InterestsPrimary research interests include the nature and treatment of eating disorders
(particularly bulimia nervosa and binge eating disorder), the development and treatment of obesity, and the development and treatment of problematic eating patterns in patients following bariatric surgery. -
Manish Saggar
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Interdisciplinary Brain Science Research)
Current Research and Scholarly InterestsWe are a computational neuropsychiatry lab dedicated to developing computational methods to better understand brain’s overall dynamical organization in healthy and patient populations. We employ algorithms from a wide range of fields, including Applied Mathematics, Econometrics, Machine Learning, Biophysics, and Network Science.
-
Gregory Lee Sahlem
Assistant Professor of Psychiatry and Behavioral Sciences (General Psychiatry and Psychology)
BioDr.Sahlem is an Assistant Professor in the Department of Psychiatry and Behavioral Sciences. He is board-certified in general psychiatry and addictions medicine, as well as fellowship-trained in the research and clinical application of neuromodulation-based treatments including repetitive Transcranial Magnetic Stimulation (rTMS), electroconvulsive therapy (ECT), and vagus nerve stimulation (VNS). He additionally has advanced training in the treatment of mood and sleep disorders. In addition to being an active clinician, Dr.Sahlem is a member of the Stanford Brain Stimulation Lab and directs the Addictions Research Section of the Lab.
Major areas of study for Dr.Sahlem include: The development of rTMS as a focused treatment for addictive disorders; the development of a novel form of ECT theorized to have reduced cognitive side effects, Focal Electrically Administered Seizure Therapy (FEAST), and; the further development of rTMS for the treatment of mood disorders. -
Khalid Salaheldin, MD
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioKhalid Salaheldin, MD, holds the position of Clinical Assistant Professor and serves as an interventional psychiatrist within the Department of Psychiatry & Behavioral Sciences at Stanford University School of Medicine. His expertise lies in the specialized care of individuals who present with early psychosis.
At Stanford, Dr. Salaheldin's current responsibilities encompass a range of clinical activities, including evaluating patients with early psychosis at the INSPIRE clinic, providing care in the inpatient psychiatric unit, and delivering interventional psychiatry services. In addition to his clinical work, he is actively engaged in teaching, conducting research, and fostering collaborative learning among his patients and colleagues.
His treatment philosophy is a recovery oriented and compassionate approach evaluating vital underlying factors alongside pharmacotherapy & neuromodulatory interventions including: sleep, exercise, nutrition, mindfulness, therapy integration, underlying medical issues, substance use, psychosocial history, and importantly patients’ current relationships (including pets of course!). His approach focuses on meeting patients where they are at in their health journey, aligning treatment with their personal goals, and being actively present in their management.
Dr. Salaheldin’s research interests include early psychosis interventions, underlying medical causes of psychiatric symptoms, neuromodulation, community/global mental health, spirituality and mental health, healthcare worker mental health, novel psychiatric therapeutics, and mental health parity & policy.
Before joining Stanford, Dr. Salaheldin served as the academic chief resident at Northwell Health, where his focus centered on designing a consult liaison service for patients experiencing a first episode of psychosis. This pioneering initiative aimed to provide compassionate support to patients and their families from the moment they arrived at the emergency room, throughout their inpatient stay, and during their transition to the outpatient setting. He hopes to continue this work on a local and global scale.
“True compassion means not only feeling another's pain, but also being moved to help relieve it. ” —Daniel Goleman -
Katherine Sanborn
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioDr Katherine Sanborn specializes in the treatment of psychiatric inpatients. She has practiced Psychiatry for more than 15 years. Dr. Sanborn has a special interests in residency education, psychotherapy training, administration and developmental psychopathology.
-
Mary Sanders, Ph.D.
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Research and Scholarly InterestsDr. Sanders is the Program Director of the Comprehensive Care Unit at Stanford where she teaches and works with inpatients with eating disorders. She has specialized in the treatment of eating disorders for the past 35 years at Stanford. She has written extensively and presented nationally on the subject of the evaluation and treatment of eating disorders and also in the field of child abuse, specifically in the area of Munchausen by proxy.
Dr. Sanders is also involved with an international outreach project in Ghana called Project Okurase. This project involved an annual medical health outreach in the village. The project is also creating a model village which includes the building of a medical clinic, vocational school, and homes for families that take in orphans. The project is also involved with bringing safe water, building compost toilets, and bringing solar energy to the village. -
Gisela Sandoval
Clinical Associate Professor, Psychiatry and Behavioral Sciences - Interdisciplinary Brain Sciences
BioDr. Gisela Sandoval is a physician scientist with dual board certification who specializes in medical-psychiatric illness caring for individuals that suffer from medical conditions at the interface of medicine and psychiatry, which often requires complex chronic care. In addition she treats children with a broad range of psychiatric disorders including neurodevelopmental disorders, ADHD and mood and anxiety disorders in adolescents. She has a thorough and comprehensive way to approach her patients; she considers not only the clinical symptoms but also the impact of the family structure and the functioning of the child at school. Dr. Sandoval has a special interest in establishing standard of care guidelines to address the needs of chronically ill children to promote healthy habits and medical treatment compliance that promote health and decrease the burden of chronic medical and psychiatric illness.
Dr. Sandoval graduated with honors from the California Institute of Technology where she performed research in brain physiology and evolution. She earned her medical degree from Harvard Medical School where she also completed a Ph.D. specializing in molecular neurobiology and genetics. Dr. Sandoval completed her residency in general psychiatry at the University of Chicago, during which she received the NIMH Outstanding Resident Award. She went on to complete a fellowship in child and adolescent psychiatry at the New York-Presbyterian Hospital Child and Adolescent Psychiatry Residency of Columbia and Cornell Universities. After training she became the Clinical Director of the Warren Wright Adolescent Center at Northwestern University developing a successful clinical program focused on early identification and intervention for adolescents at risk of mental illness before moving to Stanford.
Dr. Sandoval scientific interests focus on understanding the molecular, neurophysiological and neural circuits that are responsible for healthy brain development and behavior and understanding how these are altered in the developmental neuropsychiatric disorders resulting in pathological behaviors with the expectation that that could lead to new treatments. Furthermore, she is interested in identifying quantifiable metrics of behavior to better diagnosis mental illness by exploring the use of physical activity monitors to help assess the effectiveness of medical therapies. -
Maureen Satyshur
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
BioDr. Satyshur is a licensed clinical psychologist who specializes in Acceptance and Commitment Therapy, Dialectical Behavioral Therapy, as well as interventions for LGBTQ+ individuals.
-
Vidushi Savant
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
BioDr. Savant specializes in the treatment of comorbid psychiatric disorders in medically ill patients.
She is a double board certified in Psychosomatic Medicine and General Psychiatry. -
Parnika Prashasti Saxena
Clinical Associate Professor, Psychiatry and Behavioral Sciences
BioParnika Saxena is board certified in general and geriatric psychiatry. She completed her residency at St Elizabeth's Medical Center (affiliated with Tufts University School of Medicine) in Massachusetts and a clinical geriatric fellowship at the University of California, Los Angeles. She also worked as a research fellow in Clinical Psychopharmacology at Mclean Hospital (affiliated with Harvard Medical School) and also completed a psychoanalytic psychotherapy fellowship from the Boston Psychoanalytic Society and Institute. Her primary research interests lie in pharmacological and interventional treatments for resistant depression. At Stanford, she works on the inpatient service, outpatient geropsychiatry clinic and the electroconvulsive therapy service. She also serves at the program director of the Geriatric Psychiatry Fellowship. In addition to her clinical and research interests, she is passionate about patient advocacy and promoting mental health legislative changes to benefit patient care and has testified in state senate hearings to that end as a physician representative of organizations like the Northern California Psychiatric Association and American Psychiatric Association.
-
Blake K. Scanlon, Ph.D.
Adjunct Lecturer, Psych/Public Mental Health & Population Sciences
BioThe overarching aim of Dr. Scanlon’s research is to develop and evaluate low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. To that end, the Caregiver Technology Division of the Scanlon Lab aims to enhance patient- and family-centered care through novel, broadly customizable, and highly scalable caregiver interventions. In parallel, the Neurodegenerative Division of the Scanlon Lab focuses on the development and application of cognitive, neuropsychiatric, and biological markers for the initiation and progression of neurodegeneration.
Dr. Scanlon received his bachelor’s degree in Neuroscience and doctorate in Clinical Health Psychology from the University of Miami. After concluding his clinical internship in Geropsychology/Neuropsychology at the VA Palo Alto Health Care System (VAPAHCS), he completed fellowships in Aging and Dementia at Stanford University School of Medicine and VAPAHCS. Dr. Scanlon is currently a VA Career Development Awardee in the Sierra-Pacific Mental Illness Research, Education, and Clinical Center (MIRECC) and Stanford/VA Aging Clinical Research Center where his work focuses on developing and evaluating low-cost, pragmatic and clinically translatable methods for improving management of neurodegenerative disease and dementia. He also serves as Co-Director of the Stanford/VA California Alzheimer's Disease Center, Chair of the VAPAHCS Dementia Committee, and Co-Chair of the Department of Veterans Affairs VISN 21 Dementia Committee. -
Alan F. Schatzberg
Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsBiological bases of depressive disorders;, glucocorticoid/dopamine interactions in delusional depression;, pharmacologic treatment of depressive disorders.
-
Mariana Schmajuk
Clinical Assistant Professor, Psychiatry and Behavioral Sciences
Clinical Assistant Professor, Psychiatry and Behavioral SciencesBioMariana Schmajuk received her medical school education at Boston University School of Medicine in 2012. She completed her General Adult Psychiatry Residency program Mount Sinai School of Medicine in New York in 2016, serving as Chief Resident with a focus on the early transition from medical school to residency. She went on to complete her Consult-Liaison fellowship at New York-Presbyterian Hospital Columbia University Medical Center in 2017.
Dr. Schmajuk joined Stanford University CLP team in 2017. She is a primary member of the emergency medicine consultations, working collaboratively with a nurse practioner, social worker and residents. Clinically, Dr. Schmajuk focuses on treating patients with terminal neurological disorders and oncological processes. Dr. Schmajuk is the director of the Psychosomatic Continuity clinic where residents and fellows are able to assess and longitudinally treat patients with psychiatric sequela in the context of complex medical illness. She has a particular interest in brief psychotherapeutic interventions. She enjoys teaching medical students about CL psychiatry and interviewing skills. At present, Dr. Schmajuk is using techniques of applied improvisation to educate psychiatry residents and others about the building blocks of communication. She also is an active member of the bioethics committee. -
Logan Schneider
Adjunct Clinical Associate Professor, Psychiatry and Behavioral Sciences
Current Research and Scholarly InterestsFrom a research perspective, my long-term career plan is to refine the understanding of normal and dysfunctional sleep, much like the Epilepsy Phenome/Genome Project (EPGP) and Epi4K are doing for the enigmatic epilepsies. Insufficient sleep has been deemed a public health problem with poorly understood behavioral and physiologic sleep disorders lying at the core of the issue. I am currently using well-defined distinct and objective phenotypes (e.g. periodic limb movements, hypocretin-deficient narcolepsy) to acquire the analytic skills necessary to expand my knowledge of both signal processing and genetics, with the former enhancing my ability to identify and/or refine sleep phenotypes, and the latter facilitating the pathophysiological understanding of these phenotypes. As a consequence of a better link between symptoms/phenotypes, physiology, and genetic risks, more personally targeted and effective therapeutics can be developed to address the enriched spectrum of sleep disorders.
